Document is current
Any future updates will be listed below
-
Authors
Holladay, Emily E.
Mudano, Amy S.
Xie, Fenglong
Zhang, Jingyi
Mikuls, Ted R.
LaMoreaux, Brian
Padnick-Silver, Lissa
Curtis, Jeffrey R. http://orcid.org/0000-0002-8907-8976
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR072583)
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 24 March 2024
First Online: 12 April 2024
Declarations
:
: This study was reviewed and approved by the University of Alabama at Birmingham Institutional Review Board (Birmingham, AL). This study was classified as exempt, waiving the requirement of informed consent. All study conduct adhered to the tenets of the Declaration of Helsinki.
: Not applicable.
: EEH, ASM, FX, and JZ declare no conflicts of interest. TRM receives support from Elsevier, UpToDate, Horizon (now Amgen Inc.), Pfizer, Sanofi, UCB, and the Rheumatology Research Foundation. BL and LPS are employees of and stockholders in Horizon Therapeutics (now Amgen Inc.). JRC receives support for unrelated work from AbbVie, Amgen, Aqtual, Bendcare, BMS, CorEvitas, FASTER, GSK, Janssen, Lilly, Moderna, Novartis, Pfizer, Sanofi, Scipher, Setpoint, TNacity Blue Ocean, and UCB.
